Table 1.
Baseline Patient Characteristics
| Baseline Demographics | ONO‐4474 (n = 55) | Placebo (n = 55) |
|---|---|---|
| Sex, n (%) | ||
| Male | 18 (32.7) | 24 (43.6) |
| Female | 37 (67.3) | 31 (56.4) |
| Age, y | ||
| Mean (SD) | 61.3 (7.3) | 62.5 (8.9) |
| Body weight, kg | ||
| Mean (SD) | 67.38 (15.32) | 66.16 (14.49) |
| BMI, kg/m2 | ||
| Mean (SD) | 25.95 (4.16) | 25.60 (4.43) |
| Duration of OA, y | ||
| Mean (SD) | 4.72 (4.29) | 4.84 (5.80) |
| Kellgren‐Lawrence grade, n (%) | ||
| 2 | 19 (34.5) | 23 (41.8) |
| 3 | 28 (50.9) | 20 (36.4) |
| 4 | 8 (14.5) | 12 (21.8) |
| Use of rescue treatment in screening period, n (%) | ||
| Yes | 28 (50.9) | 23 (41.8) |
| No | 27 (49.1) | 32 (58.2) |
BMI, body mass index; OA, osteoarthritis; SD, standard deviation.